Walnut, IgE with component reflex

Alphabetical Test listing

Walnut, IgE with component reflex-994

  
Walnut, IgE with component reflex
  
994
  
LAB994
  
MSO
  
Allergen
  

Possible reflex testing

  
Serum
  
  
1.0 mL
  
0.5 mL
  

Spin

  

Gold serum separator (SST) tube

  
  

Spin and separate

  
  

Ambient (preferred) - 14 days

Refrigerated - 14 days

Frozen - 3 months

  
LabCorp Burlington (604600): R-NX
  
Daily
  
2 - 5 days
  

ImmunoCAP®

  

> 0.10 kU/L

  

The measurement of specific immunoglobulin E (IgE) to individual components of an allergen, either purified native or recombinant, is referred to as component resolved diagnosis (CRD). This approach represents an improvement over traditional measurement of IgE to allergen extracts that contain a mixture of proteins. The pattern of specific IgE reactivity to component allergens can predict which patients are at higher risk for systemic allergic reactions versus those who are sensitized but clinically tolerant. CRD can also be used to predict which patients are at risk for more severe reactions and which patients are likely to have milder symptoms.

Allergies to plant-derived foods can occur as the result of sensitization to relatively stable proteins, such as the seed storage or lipid transfer proteins. Sensitization to this type of protein can be associated with more severe, systemic reactions and a higher risk for anaphylaxis. Alternatively, allergies to plant-derived foods may occur in pollen-sensitized individuals due to pollen allergens that cross-react with food allergens. Examples of pollen-associated allergens are the profilins or PR10 proteins that are homologues of the major white birch pollen antigen Bet v 1. Allergy to this family of proteins is associated with symptoms that are generally limited to the oropharyngeal area (commonly referred to as the oral allergy syndrome of pollen food allergy syndrome).

Component resolved diagnostics can help to:
• Distinguish between allergy due to cross-reactivity and primary allergy.
• Improve the risk assessment using allergen components.
• Improve management of allergic patients.

  
86003
  
Yes
  
  
Result 6273-7
  
05/20/2019
  
05/29/2019